Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Aparicio

Showing results (41-50 of 199) with videos related to

Pageof 20
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|December 26, 2018
Obesity survival paradox in cancer patients: Results from the Physical Frailty in older adult cancer patients (PF-EC) studyFrederic Pamoukdjian, Thomas Aparicio, Florence Canoui-Poitrine, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Long-term efficacy of radionuclide therapy in patients with disseminated neuroendocrine tumors uncontrolled by conventional therapyCharles Nguyen, Marc Faraggi, Anne-Laure Giraudet, et al.
Cancer Research|November 18, 2008
Leptin receptor-related immune response in colorectal tumors: the role of colonocytes and interleukin-8Mohammad Abolhassani, Nijez Aloulou, Marie Thérèse Chaumette, et al.
Therapeutic Advances in Medical Oncology|September 24, 2024
Metastatic perirectal PEComa treated by checkpoint inhibitor immunotherapy and multimodal treatment: case report and review of the literatureMaxime Rémond, Atanas Pachev, Maxime Battistella, et al.
Cancer|March 23, 2011
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO studyAziz Zaanan, Mélanie Gauthier, David Malka, et al.
World Journal of Gastrointestinal Oncology|September 28, 2019
Colorectal cancer fecal screening test completion after age 74, sources and outcomes in French programAkoï Koïvogui, Christian Balamou, Raushan Rymzhanova, et al.
Cancers|March 10, 2022
Overall Survival and Prognostic Factors among Older Patients with Metastatic Pancreatic Cancer: A Retrospective Analysis Using a Hospital DatabaseCatherine Conti, Frédéric Pamoukdjian, Thomas Aparicio, et al.
Oncology|January 25, 2012
Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter studyMaximilien Barret, David Malka, Thomas Aparicio, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2020
Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancerJacques Lerman, Christophe Hennequin, Isabelle Etienney, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 14, 2018
Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter studyNassim Hammoudi, Clarisse Eveno, Jérôme Lambert, et al.
Pageof 20

Showing results (41-50 of 199) with videos related to

Sort By:
Pageof 20
Clinical Nutrition (Edinburgh, Scotland)|December 26, 2018
Obesity survival paradox in cancer patients: Results from the Physical Frailty in older adult cancer patients (PF-EC) studyFrederic Pamoukdjian, Thomas Aparicio, Florence Canoui-Poitrine, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Long-term efficacy of radionuclide therapy in patients with disseminated neuroendocrine tumors uncontrolled by conventional therapyCharles Nguyen, Marc Faraggi, Anne-Laure Giraudet, et al.
Cancer Research|November 18, 2008
Leptin receptor-related immune response in colorectal tumors: the role of colonocytes and interleukin-8Mohammad Abolhassani, Nijez Aloulou, Marie Thérèse Chaumette, et al.
Therapeutic Advances in Medical Oncology|September 24, 2024
Metastatic perirectal PEComa treated by checkpoint inhibitor immunotherapy and multimodal treatment: case report and review of the literatureMaxime Rémond, Atanas Pachev, Maxime Battistella, et al.
Cancer|March 23, 2011
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO studyAziz Zaanan, Mélanie Gauthier, David Malka, et al.
World Journal of Gastrointestinal Oncology|September 28, 2019
Colorectal cancer fecal screening test completion after age 74, sources and outcomes in French programAkoï Koïvogui, Christian Balamou, Raushan Rymzhanova, et al.
Cancers|March 10, 2022
Overall Survival and Prognostic Factors among Older Patients with Metastatic Pancreatic Cancer: A Retrospective Analysis Using a Hospital DatabaseCatherine Conti, Frédéric Pamoukdjian, Thomas Aparicio, et al.
Oncology|January 25, 2012
Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter studyMaximilien Barret, David Malka, Thomas Aparicio, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2020
Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancerJacques Lerman, Christophe Hennequin, Isabelle Etienney, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 14, 2018
Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter studyNassim Hammoudi, Clarisse Eveno, Jérôme Lambert, et al.
Pageof 20